LIVN

SEC source: 0001639691-25-000029 · wk-form4_1743555682.xml · derivative · entry 7

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 805 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement.

F10 · derivative.exercise_date: On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's cumulative adjusted free cash flow (FCF) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The Company has determined that 88.1% of the underlying PSUs shall vest on March 30, 2025, subject to continued service during the vesting period and the award agreement. The performance achieved was 88.1%, and the actual number of vested shares is presented as the quantity that was acquired.

F10 · derivative.expiration_date: On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's cumulative adjusted free cash flow (FCF) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The Company has determined that 88.1% of the underlying PSUs shall vest on March 30, 2025, subject to continued service during the vesting period and the award agreement. The performance achieved was 88.1%, and the actual number of vested shares is presented as the quantity that was acquired.

SEC source: 0001639691-25-000029 · wk-form4_1743555682.xml · derivative · entry 6

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,686

Underlying: Ordinary Shares · 1,229 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F8 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F8 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

SEC source: 0001639691-25-000029 · wk-form4_1743555682.xml · derivative · entry 5

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,659

Underlying: Ordinary Shares · 1,330 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F7 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F7 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

SEC source: 0001639691-25-000029 · wk-form4_1743555682.xml · derivative · entry 4

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 457

Underlying: Ordinary Shares · 457 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.

F5 · derivative.exercise_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

F5 · derivative.expiration_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

SEC source: 0001639691-25-000029 · wk-form4_1743555682.xml · derivative · entry 3

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 426 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.

F4 · derivative.exercise_date: On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

F4 · derivative.expiration_date: On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

SEC source: 0001639691-25-000029 · wk-form4_1743555682.xml · nonDerivative · entry 2

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,751

F2 · shares: Shares withheld to satisfy tax liability.

SEC source: 0001639691-25-000029 · wk-form4_1743555682.xml · nonDerivative · entry 1

Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,586

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

SEC source: 0001639691-25-000027 · wk-form4_1743555661.xml · derivative · entry 3

KOZY WILLIAM A · CIK 0001221785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,034 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on March 30, 2025, subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on March 30, 2025, subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-25-000027 · wk-form4_1743555661.xml · nonDerivative · entry 2

KOZY WILLIAM A · CIK 0001221785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,308

F2 · shares: Shares withheld to satisfy tax liability.

SEC source: 0001639691-25-000027 · wk-form4_1743555661.xml · nonDerivative · entry 1

KOZY WILLIAM A · CIK 0001221785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,496

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 9

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,581

Underlying: Ordinary Shares · 19,581 shares

Expires 2035-03-30

F12 · derivative.exercise_date: On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 8

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,944

Underlying: Ordinary Shares · 8,944 shares

Expires not disclosed

F8 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.

F11 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F11 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 7

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,472

Underlying: Ordinary Shares · 4,472 shares

Expires not disclosed

F8 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.

F10 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F10 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 6

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,472

Underlying: Ordinary Shares · 4,472 shares

Expires not disclosed

F8 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.

F9 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F9 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 5

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,944

Underlying: Ordinary Shares · 8,944 shares

Expires not disclosed

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.

F7 · derivative.exercise_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F7 · derivative.expiration_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 4

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,356

Underlying: Ordinary Shares · 1,453 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement.

F5 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F5 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,955

Underlying: Ordinary Shares · 1,477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,666

F2 · shares: Shares withheld to satisfy tax liability.

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,686

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 14

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,777

Underlying: Ordinary Shares · 23,777 shares

Expires 2035-03-30

F18 · derivative.exercise_date: On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 13

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,861

Underlying: Ordinary Shares · 10,861 shares

Expires not disclosed

F14 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F17 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's TSR for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F17 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's TSR for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 12

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,430

Underlying: Ordinary Shares · 5,430 shares

Expires not disclosed

F14 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F16 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's ROIC calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F16 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's ROIC calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 11

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,430

Underlying: Ordinary Shares · 5,430 shares

Expires not disclosed

F14 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F15 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's FCF for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F15 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's FCF for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 10

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,861

Underlying: Ordinary Shares · 10,861 shares

Expires not disclosed

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F13 · derivative.exercise_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F13 · derivative.expiration_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 9

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,120 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement.

F12 · derivative.exercise_date: On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2022 and ending December 31, 2024 relative to the total shareholder return of a peer group of companies, as determined by the 2015 Plan Administrator. The Company's performance achieved a result of 58%, and the actual number of vested shares is presented as the quantity that was acquired.

F12 · derivative.expiration_date: On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2022 and ending December 31, 2024 relative to the total shareholder return of a peer group of companies, as determined by the 2015 Plan Administrator. The Company's performance achieved a result of 58%, and the actual number of vested shares is presented as the quantity that was acquired.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 8

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement.

F11 · derivative.exercise_date: On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's Return on Investment Capital (ROIC) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The performance achieved was 78.5%, and the actual number of vested shares is presented as the quantity that was acquired.

F11 · derivative.expiration_date: On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's Return on Investment Capital (ROIC) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The performance achieved was 78.5%, and the actual number of vested shares is presented as the quantity that was acquired.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 7

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,610 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement.

F10 · derivative.exercise_date: On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's cumulative free cash flow (FCF) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The Company has determined that 88.1% of the underlying PSUs shall vest on March 30, 2025, subject to continued service during the vesting period and the award agreement. The performance achieved was 88.1%, and the actual number of vested shares is presented as the quantity that was acquired.

F10 · derivative.expiration_date: On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's cumulative free cash flow (FCF) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The Company has determined that 88.1% of the underlying PSUs shall vest on March 30, 2025, subject to continued service during the vesting period and the award agreement. The performance achieved was 88.1%, and the actual number of vested shares is presented as the quantity that was acquired.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 6

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,362

Underlying: Ordinary Shares · 1,788 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F8 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F8 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 5

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,728

Underlying: Ordinary Shares · 2,364 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F7 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F7 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 4

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 914

Underlying: Ordinary Shares · 914 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.

F5 · derivative.exercise_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

F5 · derivative.expiration_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · derivative · entry 3

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 853 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.

F4 · derivative.exercise_date: On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

F4 · derivative.expiration_date: On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · nonDerivative · entry 2

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,680

F2 · shares: Shares withheld to satisfy tax liability.

SEC source: 0001639691-25-000025 · wk-form4_1743555640.xml · nonDerivative · entry 1

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,196

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

SEC source: 0001639691-24-000150 · wk-form4_1734474176.xml · derivative · entry 4

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 967

Underlying: Ordinary Shares · 967 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the first vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the first vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-24-000150 · wk-form4_1734474176.xml · nonDerivative · entry 2

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,218

F2 · shares: Shares withheld to satisfy tax liability.

SEC source: 0001639691-24-000150 · wk-form4_1734474176.xml · nonDerivative · entry 1

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,634

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

SEC source: 0001639691-24-000149 · wk-form4_1734474167.xml · derivative · entry 3

Barry James Christopher · CIK 0001756949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,709 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2023, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2023, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-24-000149 · wk-form4_1734474167.xml · nonDerivative · entry 2

Barry James Christopher · CIK 0001756949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,356

F2 · shares: Shares withheld to satisfy tax liability.

SEC source: 0001639691-24-000149 · wk-form4_1734474167.xml · nonDerivative · entry 1

Barry James Christopher · CIK 0001756949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,709

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

SEC source: 0001639691-24-000147 · wk-form4_1734474144.xml · derivative · entry 1

PODLOGAR SUSAN M · CIK 0001709959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,355

Underlying: Ordinary Shares · 2,355 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the award agreement.

F2 · derivative.exercise_date: On December 15, 2024, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on December 15, 2025, subject to continued service during the vesting period and the award agreement.

F2 · derivative.expiration_date: On December 15, 2024, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on December 15, 2025, subject to continued service during the vesting period and the award agreement.

SEC source: 0001639691-24-000151 · wk-form4_1734474186.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,507

Underlying: Ordinary Shares · 2,254 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the second vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the second vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-24-000151 · wk-form4_1734474186.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,756

F2 · shares: Shares withheld to satisfy tax liability.

SEC source: 0001639691-24-000151 · wk-form4_1734474186.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

SEC source: 0001639691-24-000148 · wk-form4_1734474154.xml · derivative · entry 3

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 613 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2020, reporting person was granted RSUs subject to a four-year vesting schedule, the fourth and final vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2020, reporting person was granted RSUs subject to a four-year vesting schedule, the fourth and final vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-24-000148 · wk-form4_1734474154.xml · nonDerivative · entry 2

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,113

F2 · shares: Shares withheld to satisfy tax liability.

SEC source: 0001639691-24-000148 · wk-form4_1734474154.xml · nonDerivative · entry 1

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,342

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

SEC source: 0001639691-24-000141 · wk-form4_1734123829.xml · nonDerivative · entry 1

Bianchi Francesco · CIK 0001656080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,522

SEC source: 0001639691-24-000123 · wk-form4_1726603520.xml · derivative · entry 5

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,885

Underlying: Ordinary Shares · 5,885 shares

Expires 2034-09-15

F7 · derivative.exercise_date: On September 15, 2024, reporting person was granted stock appreciation rights ("SARs") subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

SEC source: 0001639691-24-000123 · wk-form4_1726603520.xml · derivative · entry 4

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,575

Underlying: Ordinary Shares · 2,575 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement.

F6 · derivative.exercise_date: On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F6 · derivative.expiration_date: On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

SEC source: 0001639691-24-000123 · wk-form4_1726603520.xml · derivative · entry 3

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,287

Underlying: Ordinary Shares · 1,287 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement.

F5 · derivative.exercise_date: On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.